Page 731 - Small Animal Internal Medicine, 6th Edition
P. 731

CHAPTER 41   Acute Kidney Injury and Chronic Kidney Disease   703


            Chew DJ. Acute renal failure. In: Chew DJ, DiBartola SP, Schenck   Nielsen LK, et al. Administration of fenoldopam in critically ill
              PA, eds. Canine and feline nephrology and urology. St Louis: Else-  small animal patients with acute kidney injury: 28 dogs and 34
  VetBooks.ir  Finch NC, et al. Fibroblast growth factor 23 (FGF-23) concentra-  Parker VJ, et al. Association between body condition and survival
              vier Saunders; 2011:63.
                                                                  cats (2008-2012).  J Vet Emerg Crit Care (San Antonio).
                                                                  2015;25:396.
              tions in cats with early nonazotemic chronic kidney disease
              (CKD) and in healthy geriatric cats. J Vet Intern Med. 2013;27:227.  in dogs with acquired chronic kidney disease. J Vet Intern Med.
            Freeman LM, et al. Evaluation of weight loss over time in cats with   2011;25:1306.
              chronic kidney disease. J Vet Intern Med. 2016;30:1661.  Plantinga EA, et al. Retrospective study of the survival of cats with
            Geddes  RF,  et al.  Relationship  between  plasma  fibroblast growth   acquired chronic renal insufficiency offered different commercial
              factor-23 concentration and survival time in cats with chronic   diets. Vet Rec. 2005;157:185.
              kidney disease. J Vet Intern Med. 2015;29:1494.    Quimby JM, et al. Mirtazapine as an appetite stimulant and anti-
            Geddes RF, et al. Fibroblast growth factor 23 (FGF-23) concentra-  emetic in cats with chronic kidney disease: a masked placebo-
              tions in cats with early nonazotemic chronic kidney disease   controlled crossover clinical trial. Vet J. 2013;197:651.
              (CKD) and healthy geriatric cats. J Vet Intern Med. 2013;27:227.  Roudebush P, et al. An evidence-based review of therapies for
            Geddes RF, et al. Fibroblast growth factor 23 in feline chronic   canine chronic kidney disease. J Small Anim Pract. 2010;51:244.
              kidney disease. J Vet Intern Med. 2013;27:234.     Shipov A, et al. The effect of naturally occurring chronic kidney
            Harjes LM, et al. Fibroblast growth factor-23 concentration in dogs   disease  on the microstructural and mechanical properties  of
              with chronic kidney disease. J Vet Intern Med. 2017;31:784.  bone. PLoS ONE. 2014;9:e110057.
            Kelly KL, et al. Effect of fenoldopam continuous infusion on glo-  Sparkes AH, et al. ISFM Consensus guidelines on the diagnosis and
              merular filtration rate and fractional excretion of sodium in   management of feline chronic kidney disease. J Feline Med Surg.
              healthy dogs. J Vet Intern Med. 2016;30:1655.       2016;18:219.
            King JN, et al. Tolerability and efficacy of benazepril in cats with   Syme HM, et al. Survival of cats with naturally occurring chronic
              chronic kidney disease. J Vet Intern Med. 2006;20:1054.  renal failure is related to severity of proteinuria. J Vet Intern Med.
            McLeland SM, et al. Relationship among serum creatinine, serum   2006;20:528.
              gastrin, calcium-phosphorus product and uremic gastropathy in   Tolbert MK, et al. Evaluation of gastric pH and serum gastrin con-
              cats  with chronic  kidney  disease.  J Vet Intern Med.  2014;28:   centrations in cats with chronic kidney disease. J Vet Intern Med.
              827.                                                2017.
   726   727   728   729   730   731   732   733   734   735   736